Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation

Innate Immunity

Volumn 15, Issue 4, 2009, Pages 251-258

  Tamagawa, Eiji ^a   Suda, Koichi ^a   Wei, Yuan ^a   Xing, Li ^a   Mui, Tammy ^a   Li, Yuexin ^a   van Eeden, Stephan F ^a   Man, S F Paul ^a   Sin, Don D ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Endotoxin; Interleukin 6; Systemic Inflammation; Translocation

Indexed keywords

ALBUMIN; DEXAMETHASONE; ENDOTOXIN; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CENTRAL VEIN; CONTROLLED STUDY; CYTOKINE RELEASE; DENSITY GRADIENT; HEART RIGHT ATRIUM; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; SYSTEMIC CIRCULATION; VENOUS BLOOD;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD CIRCULATION; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENDOTOXINS; INTERLEUKIN-6; INTUBATION, INTRATRACHEAL; LUNG; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA;

ANIMALIA; MURINAE; MUS;

EID: 67949111074     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425909104782     Document Type: Article

References (34)

1. Chalmers JD, Singanayagam A., Hill AT C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008; 121: 219-225.
2. Gompertz S., Bayley DL, Hill SL, Stockley RA Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 2001; 56: 36-41.
3. Nel AE, Strachan AF, Welke HE, de Beer FC Acute phase response in bronchiectasis and bronchus carcinoma. Respiration 1985; 47: 196-200.
4. Russell JA Management of sepsis. N Engl J Med 2006; 355: 1699-1713.
5. Tyburski JG, Dente C., Wilson RF et al. Differences in arterial and mixed venous IL-6 levels: The lungs as a source of cytokine storm in sepsis. Surgery 2001; 130: 748-751.
6. Oberholzer A., Souza SM, Tschoeke SK et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005; 23: 488-493.
7. Pathan N., Hemingway CA, Alizadeh AA et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004; 363: 203-209.
8. Pettila V., Hynninen M., Takkunen O., Kuusela P., Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28: 1220-1225.
9. Wakefield CH, Barclay GR, Fearon KC et al. Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis. Scottish Sepsis Intervention Group. Br J Surg 1998; 85: 818-825.
10. Kellum JA, Kong L., Fink MP et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch Intern Med 2007; 167: 1655-1663.
11. Schefold JC, von Haehling S., Corsepius M. et al. A novel selective extracorporeal intervention in sepsis: Immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a. Shock 2007; 28: 418-425.
12. Hasday JD, Bascom R., Costa JJ, Fitzgerald T., Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115: 829-835.
13. Hollingsworth JW, Chen BJ, Brass DM et al. The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am J Respir Crit Care Med 2005; 171: 806-813.
14. Giebelen IA, van Westerloo DJ, LaRosa GJ, de Vos AF, van der Poll T. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 2007; 28: 700-703.
15. Cheng C., Pounds S. False discovery rate paradigms for statistical analyses of microarray gene expression data. Bioinformation 2007; 1: 436-446.
16. Terashima T., Wiggs B., English D., Hogg JC, van Eeden SF The effect of cigarette smoking on the bone marrow. Am J Respir Crit Care Med 1997; 155: 1021-1026.
17. van Eeden SF, Sin DD Chronic obstructive pulmonary disease: A chronic systemic inflammatory disease. Respiration 2008; 75: 224-238.
18. Rull M., Clayburne G., Sieck M., Schumacher HR Intra-articular corticosteroid preparations: Different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch. Rheumatology (Oxford) 2003; 42: 1093-1100.
19. Umeno E., McDonald DM, Nadel JA Hypertonic saline increases vascular permeability in the rat trachea by producing neurogenic inflammation. J Clin Invest 1990; 85: 1905-1908.
20. Muhlfeld C., Gehr P., Rothen-Rutishauser B. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly 2008; 138: 387-391.
21. Moller W., Felten K., Sommerer K. et al. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 2008; 177: 426-432.
22. Nemmar A., Hamoir J., Nemery B., Gustin P. Evaluation of particle translocation across the alveolo-capillary barrier in isolated perfused rabbit lung model. Toxicology 2005; 208: 105-113.
23. Levine MM, Kaper JB, Black RE, Clements ML New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev 1983; 47: 510-550.
24. Martin TR Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 2000; 23: 128-132.
25. Gamble L., Bagby GJ, Quinton LJ et al. The systemic and pulmonary lipopolysaccharide binding protein response to intratracheal lipopolysaccharide. Shock 2009; 31: 212-217.
26. Ek A., Palmberg L., Larsson K. The effect of fluticasone on the airway inflammatory response to organic dust. Eur Respir J 2004; 24: 587-593.
27. Khair OA, Davies RJ, Devalia JL Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996; 9: 1913-1922.
28. Danesh J., Kaptoge S., Mann AG et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 2008; 5: E78.
29. Hong DS, Angelo LS, Kurzrock R. Interleukin-6 and its receptor in cancer: Implications for translational therapeutics. Cancer 2007; 110: 1911-1928.
30. Kishimoto T. Interleukin-6: Discovery of a pleiotropic cytokine. Arthritis Res Ther 2006; 8: S2.
31. Mudter J., Neurath MF IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007; 13: 1016-1023.
32. Rose-John S., Waetzig GH, Scheller J., Grotzinger J., Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 2007; 11: 613-624.
33. Tamagawa E., Bai N., Morimoto K. et al. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol 2008; 295: L79-L85.
34. Ishii H., Hayashi S., Hogg JC et al. Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment. Respir Res 2005; 6: 87.